+91-7291089674 (Bandra)
+91-7291092120 (Kandivali)
Glaucoma usually does not result in blindness when treated properly. However, without treatment, it will gradually lead to blindness. Glaucoma-related vision loss usually occurs gradually and is one of the leading causes of irreversible blindness worldwide. With timely treatment and effective management, the progression of vision loss can often be slowed or even completely stopped.
Read MoreJanuary is Glaucoma Awareness Month, making it the perfect time to talk about how to spread the word about this condition that can cause blindness. Early detection of glaucoma is necessary for receiving proper treatment. Alarming key facts about glaucoma:
Read MoreGlaucoma is a serious medical condition related to the eyes. If left untreated, it may silently cause permanent loss of vision. It damages the optic nerve (nerve of your eyes).
Read More
Glaucoma is a condition in which increased intraocular pressure leads to alteration in the visual function. The symptoms of glaucoma are believed to be caused due to pressure on the posterior part of the eye, especially the lamina cribrosa, which is a part of the back of the eye where the sclera gives way to
Read More
Trabeculectomy is the surgical procedure to treat the increased Intra-ocular pressure, the condition medically known as glaucoma. The surgery involves removing a small piece of trabecular meshwork by making a tiny hole in the eye. The surgery is regarded as the Gold Standard in the management of intra-ocular pressure when other measures to bring down
Read More
Before initiating the discussion about the relationship between the autoimmune disease and glaucoma, let’s have a quick review of the impact of the immune system on eyes. The body has various sites that are immune privileged. These sites are places in the body where the graft tissues can be placed without any concern of tissue
Read More
A new innovation in Glaucoma treatment. The Beacon Aqueous Microshunt (MicroOptix) – the brain child of David Brown, MD, 20 years in development-is 3.1 mm in length with an external flange width of 7 mm. It is implanted into a paracentesis-like incision, allowing aqueous to flow through a central channel. Mitigation against retrograde flow of
Read More
